Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (9): 568-569.
DOI: 10.19803/j.1672-8629.2019.09.10
Previous Articles Next Articles
ZHU Kouzhu, CHEN Yanhua, HONG Yuan
Received:2019-01-16
Revised:2019-10-21
Online:2019-09-20
Published:2019-10-21
CLC Number:
ZHU Kouzhu, CHEN Yanhua, HONG Yuan. One Case of Severe Drug Eruption Induced by Piperacillin Sodium and Tazobactam for Injection in Children[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 568-569.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2019.09.10
| [1] 张浩川,王爱和,赵一鸣,等. 小儿先天性胆总管囊肿胆汁细菌培养及药敏分析[J]. 中华医院感染学杂志,2011,21(6):1 265-1 267. [2] 李婵娟. 奥美拉唑致多形性红斑一例[J]. 山西医药杂志(下半月刊),2011,(3):276. [3] 杨澍,崔艳丽,高秀清,等. β-内酰胺酶抑制剂复合制剂的不良反应文献分析[J]. 现代药物与临床,2016,31(1):106-110. [4] 毛孝钢,周华, 张媛媛, 等. β-内酰胺类抗菌药物致药物热的研究[J]. 中国现代应用药学,2016,33(6):822-824. [5] Naranjo C A,Busto U,Selters E M,et al.A method for estimating the probability of adverse drug reactions[J].Clinical Pharmacology & Therapeutics,1981,30(2):239-245. [6] Pereira F A,Mudgil A V,Rosmarin D M.Toxic epidermal necrolysis[J].Journal of the American Academy of Dermatology,2007,56(2):181-195 [7] 金伯泉. 医学免疫学[M].北京:人民卫生出版社,2008:185-186. [8] 张文竹,张媛媛,赵艳. 哌拉西林钠他唑巴坦钠致小儿渗出性多形红斑型药疹[J]. 药物不良反应杂志,2016,18(2):137-138. [9] 刘立立,黄玲,胡正波,等. 哌拉西林钠他唑巴坦钠致大疱表皮松解型药疹1例[J]. 中国药物警戒,2013,10(11):703-704. [10] 李黎. 警惕哌拉西林他唑巴坦引起的迟发型过敏反应[J].临床医药文献电子杂志,2016,3(30):6100. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
